In 2025, medical device manufacturers are grappling with heightened regulatory uncertainty, leading to slower reviews and communication difficulties with the FDA. This situation drives them to reassess operations for compliance and risk management, with a strong emphasis on maintaining product quality, which is vital for patient safety.
Why it Pays to Prioritize Quality Amid Regulatory Uncertainty
Related Posts
Association for Advancing Automation Celebrates Golden Anniversary
Organization to commemorate a legacy of 50 years of advancing automation and robotics technologies throughout 2024, with major…
What an 1894 Crisis Has in Common with the Climate Change Crisis
The 1894 Horse Manure Crisis revealed the negative effects of rapid industrialization. Today, we can learn from past…
Instron 100 kN Table Model Universal Testing System
Instron® announced the release of its new 100 kN table model for the 6800 and 3400 Series universal…